| Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities R Motterlini, JE Clark, R Foresti, P Sarathchandra, BE Mann, CJ Green Circulation research 90 (2), e17-e24, 2002 | 1208 | 2002 |
| Cardioprotective actions by a water-soluble carbon monoxide–releasing molecule JE Clark, P Naughton, S Shurey, CJ Green, TR Johnson, BE Mann, ... Circulation research 93 (2), e2-e8, 2003 | 815 | 2003 |
| Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction JE Clark, R Foresti, P Sarathchandra, H Kaur, CJ Green, R Motterlini American Journal of Physiology-Heart and Circulatory Physiology 278 (2 …, 2000 | 597 | 2000 |
| Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress JE CLARK, R FORESTI, CJ GREEN, R MOTTERLINI Biochemical Journal 348 (3), 615-619, 2000 | 411 | 2000 |
| Vasoactive properties of CORM‐3, a novel water‐soluble carbon monoxide‐releasing molecule R Foresti, J Hammad, JE Clark, TR Johnson, BE Mann, A Friebe, ... British journal of pharmacology 142 (3), 453-460, 2004 | 386 | 2004 |
| Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells: involvement of superoxide and peroxynitrite anions R Foresti, JE Clark, CJ Green, R Motterlini Journal of Biological Chemistry 272 (29), 18411-18417, 1997 | 377 | 1997 |
| Endothelial Heme Oxygenase-1 Induction by Hypoxia: MODULATION BY INDUCIBLE NITRIC-OXIDE SYNTHASE ANDS-NITROSOTHIOLS R Motterlini, R Foresti, R Bassi, V Calabrese, JE Clark, CJ Green Journal of Biological Chemistry 275 (18), 13613-13620, 2000 | 370 | 2000 |
| Heme oxygenase-1–derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo R Motterlini, A Gonzales, R Foresti, JE Clark, CJ Green, RM Winslow Circulation research 83 (5), 568-577, 1998 | 367 | 1998 |
| Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase‐1 IA Sammut, R Foresti, JE Clark, DJ Exon, MJJ Vesely, P Sarathchandra, ... British journal of pharmacology 125 (7), 1437-1444, 1998 | 334 | 1998 |
| Metal carbonyls: a new class of pharmaceuticals? TR Johnson, BE Mann, JE Clark, R Foresti, CJ Green, R Motterlini Angewandte Chemie International Edition 42 (32), 3722-3729, 2003 | 331 | 2003 |
| Bioactivity and pharmacological actions of carbon monoxide-releasing molecules R Motterlini, BE Mann, TR Johnson, JE Clark, R Foresti, CJ Green Current pharmaceutical design 9 (30), 2525-2539, 2003 | 327 | 2003 |
| Peroxynitrite induces haem oxygenase-1 in vascular endothelial cells: a link to apoptosis R FORESTI, P SARATHCHANDRA, JE CLARK, CJ GREEN, ... Biochemical Journal 339 (3), 729-736, 1999 | 309 | 1999 |
| Aged‐senescent cells contribute to impaired heart regeneration FC Lewis‐McDougall, PJ Ruchaya, E Domenjo‐Vila, T Shin Teoh, L Prata, ... Aging cell 18 (3), e12931, 2019 | 292 | 2019 |
| Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury WJ Schwaeble, NJ Lynch, JE Clark, M Marber, NJ Samani, YM Ali, ... Proceedings of the National Academy of Sciences 108 (18), 7523-7528, 2011 | 258 | 2011 |
| The role of single-incision laparoscopic surgery in abdominal and pelvic surgery: a systematic review K Ahmed, TT Wang, VM Patel, K Nagpal, J Clark, M Ali, S Deeba, ... Surgical endoscopy 25, 378-396, 2011 | 212 | 2011 |
| Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse Y Nishino, IG Webb, SM Davidson, AI Ahmed, JE Clark, S Jacquet, ... Circulation research 103 (3), 307-314, 2008 | 159 | 2008 |
| Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease JE Clark, N Sarafraz, MS Marber Pharmacology & therapeutics 116 (2), 192-206, 2007 | 139 | 2007 |
| Thymosin β4 facilitates epicardial neovascularization of the injured adult heart N Smart, CA Risebro, JE Clark, E Ehler, L Miquerol, A Rossdeutsch, ... Annals of the New York Academy of Sciences 1194 (1), 97-104, 2010 | 128 | 2010 |
| A novel α-calcitonin gene-related peptide analogue protects against end-organ damage in experimental hypertension, cardiac hypertrophy, and heart failure AA Aubdool, P Thakore, F Argunhan, SJ Smillie, M Schnelle, S Srivastava, ... Circulation 136 (4), 367-383, 2017 | 110 | 2017 |
| Targeting p38-MAPK in the ischaemic heart: kill or cure? R Bassi, R Heads, MS Marber, JE Clark Current opinion in pharmacology 8 (2), 141-146, 2008 | 97 | 2008 |
Roberto MotterliniDirector of Research (DR1), INSERM U955, University Paris Est Créteil, FranceAdresse e-mail validée de inserm.fr